Evidence map›Paper›PMID 37488801›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[STIP1 correlates with tumor immune infiltration and prognosis as a potential immunotherapy target: a pan-cancer bioinformatics analysis].

S Guan, Z Shen, M Lin, H Deng, Y Fang

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S GuanDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z ShenDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
M LinDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
H DengDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Y FangDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the correlation of stress-inducible phosphoprotein 1 (STIP1) expression level with prognosis of different cancers and its potential role in immunotherapy.

methodsTCGA, TARGET and GTEx databases were used for bioinformatic analysis of STIP1 expression level and its prognostic value in different cancers. We also detected STIP1 expression immunohistochemically in 10 pairs of colorectal cancer and adjacent tissues. We further analyzed the correlation of STIP1 expression level with tumor mutational burden, microsatellite instability, immune cell infiltration, immune regulators and outcomes of different cancers. STIP1- related proteins were identified using protein- protein interaction (PPI) network analysis, and functional enrichment analysis was performed to analyze the regulatory pathways involving STIP1.

resultsBioinformatics analysis showed that STIP1 was highly expressed in most tumors compared with the normal tissues (

conclusionSTIP1 is up-regulated in multiple cancer types and its expression level is correlated with clinical tumor stage, tumor mutational burden, microsatellite instability, immune cell infiltration and immunomodulatory factors.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsComputational BiologyHeat-Shock ProteinsHumansImmunotherapyMicrosatellite InstabilityPrognosisHeat-Shock ProteinsSTIP1 protein, humanimmune-related genepan-cancer analysisstress induced phosphoprotein 1stress-inducible phosphoprotein 1

Identifiers

PMID37488801
PMCPMC10366520
OpenAlexW4385231145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.